Cargando…

Hodgkin's lymphoma in developing countries: can we go further?()

Detalles Bibliográficos
Autor principal:	Gaiolla, Rafael Dezen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2017
Materias:	Scientific comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693266/ https://www.ncbi.nlm.nih.gov/pubmed/29150100 http://dx.doi.org/10.1016/j.bjhh.2017.08.004

Ejemplares similares

New agents in relapsed/refractory Hodgkin's lymphoma()
por: Biasoli, Irene, et al.
Publicado: (2017)

A step towards the cure of Burkitt's lymphoma in developing countries
por: Klumb, Claudete Esteves
Publicado: (2012)

Post-Ganglionic Horner's Syndrome: An Unusual Presentation of Non-Hodgkin Lymphoma
por: Ruiz e Resende, Lucilene Silva, et al.
Publicado: (2012)

SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma
por: Gaiolla, Rafael Dezen, et al.
Publicado: (2021)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines
por: Barbosa, Maurício Fregonesi, et al.
Publicado: (2021)

Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
por: Aurer, Igor, et al.
Publicado: (2020)

Concerts and COVID: can the beat go on?
por: Schlagenhauf, Patricia, et al.
Publicado: (2022)

Lymphoma: streamlining follow ups
por: Hallack Neto, Abrahão Elias
Publicado: (2013)

Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015)

Antimicrobial-resistant Shigella: where do we go next?
por: Baker, Stephen, et al.
Publicado: (2023)

Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma
por: Hasserjian, Robert P., et al.
Publicado: (2009)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023)

Further We Travel the Faster We Go
por: Varga, Levente, et al.
Publicado: (2016)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

Compound heterozygosity for hemoglobin S and D: what do we need to know?()
por: Bonini-Domingos, Claudia Regina
Publicado: (2016)

Public communication about public health where we really need to go
por: Ranney, Megan L., et al.
Publicado: (2022)

National neonatal screening program for hemoglobinopathies: how far have we advanced?()
por: da Fonseca, Silvana Fahel
Publicado: (2014)

Reflections on patient engagement by patient partners: how it can go wrong
por: Richards, Dawn P., et al.
Publicado: (2023)

We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas()
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2014)

Life on Mars, can we detect it?
por: Stoker, Carol R.
Publicado: (2023)

ABO isohemagglutinin titration or hemolysin test: what should we do to reduce the risk of passive hemolysis?()
por: Castilho, Lilian
Publicado: (2015)

Exposure to artificial light at night and risk of cancer: where do we go from here?
por: Jones, Rena R.
Publicado: (2021)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

COVID-19 and EU Climate Targets: Can We Now Go Further?
por: Meles, Tensay Hadush, et al.
Publicado: (2020)

Predictors of central nervous system involvement in diffuse large B-cell lymphoma: a divining rod is wanted
por: Ferreri, Andrés José María
Publicado: (2013)

Comment to: Hernia research in developing countries: are we looking for needles in haystacks? Insights from the Danish model
por: Jorgensen, L. N., et al.
Publicado: (2020)

Diarrhea after autologous stem cell transplantation in low-middle income countries: is Clostridium difficile the most prevalent infectious etiology?()
por: Cunha, Renato
Publicado: (2018)

Diffuse large B cell gastric lymphoma a rare disease: the effort to obtain scientific data in a multicenter, multinational retrospective trial()
por: Hamerschlak, Nelson
Publicado: (2016)

Tides within ourselves: how posture can affect blood volume, blood cells and clinical reasoning()
por: De Paula, Erich Vinicius
Publicado: (2017)

Plasma cells in classical Hodgkin lymphoma: a new player in the microenvironment?
por: Visser, Lydia
Publicado: (2018)

Lung cancer and Covid-19: lessons learnt from the pandemic and where do we go from here?
por: Maxwell, Susanne Sarah, et al.
Publicado: (2022)

The RF system to 102 GeV: how did we get there and can we go further?
por: Sladen, Jonathan P H
Publicado: (2000)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
por: Eichenauer, Dennis A., et al.
Publicado: (2023)

Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
por: Rocha, Talita Máira Bueno da Silveira da, et al.
Publicado: (2017)

In the 2020 US election, we can choose a just future
por: Boyd, Rhea W, et al.
Publicado: (2020)

How can we get sober from the influence of the alcohol industry?
por: Monteiro, Maristela G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m0ggj71euvr0jn80gkabk048uv